Roche to Buy InterMune for $8.3B, Adds Lung Drug
Aug. 25 (Bloomberg) -- Roche is strengthening its portfolio of medicines for respiratory ailments with an agreement to buy InterMune for $8.3 billion in cash. Olivia Sterns reports on “In The Loop.” (Source: Bloomberg)
Most Recent Videos
"Preserving Bombardier C-Series Key Amid 7,500 Job Cuts"
07:30 - Bombardier has announced it will slash 7,500 jobs during a second round of job cuts within the past 8 months. Bloomberg Intelligence Analyst George Ferguson explains whether these cost saving measures were necessary as the struggling aircraft maker awaits $1 billion in federal aid from the Canadian government on Bloomberg TV Canada's The Daily Brief. (Source: Bloomberg)